Close Window

Digital Look Email A Friend

Avacta reports promising results from ongoing clinical trial

Published by Josh White on 16th January 2025

(Sharecast News) - Avacta Therapeutics announced promising results from its ongoing phase 1a trial of AVA6000 on Thursday, demonstrating meaningful tumour shrinkage in patients with salivary gland cancer (SGC).

URL: http://www.digitallook.com/dl/news/story/34817260/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.